Literature DB >> 23911160

Biosimilar insulin and insulin antibodies.

Lutz Heinemann, David Owens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23911160      PMCID： PMC3879743          DOI： 10.1177/193229681300700401

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  3 in total

1.  The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.

Authors:  Tim Heise; Susanne Bott; Corinna Tusek; Jens-Armin Stephan; Tom Kawabata; Deborah Finco-Kent; Cameron Liu; Alan Krasner
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

Review 2.  The emergence of biosimilar insulin preparations--a cause for concern?

Authors:  David R Owens; Wolfgang Landgraf; Andrea Schmidt; Reinhard G Bretzel; Martin K Kuhlmann
Journal:  Diabetes Technol Ther       Date:  2012-10-09       Impact factor: 6.118

Review 3.  Biosimilar insulins.

Authors:  Lutz Heinemann
Journal:  Expert Opin Biol Ther       Date:  2012-05-15       Impact factor: 4.388
  3 in total
  1 in total

1.  Multiple Source Biosimilar Insulin, What's a Provider to Do?

Authors:  Alan Carter
Journal:  J Diabetes Sci Technol       Date:  2014-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.